X-120076964-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The ENST00000371402.5(RHOXF2B):āc.404A>Cā(p.Gln135Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000032 ( 0 hom., 1 hem., cov: 9)
Exomes š: 0.0000046 ( 0 hom. 4 hem. )
Failed GnomAD Quality Control
Consequence
RHOXF2B
ENST00000371402.5 missense
ENST00000371402.5 missense
Scores
2
15
Clinical Significance
Conservation
PhyloP100: -2.59
Genes affected
RHOXF2B (HGNC:33519): (Rhox homeobox family member 2B) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in positive regulation of gene expression. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.087367654).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHOXF2B | NM_001099685.3 | c.404A>C | p.Gln135Pro | missense_variant | 2/4 | ENST00000371402.5 | NP_001093155.1 | |
RHOXF1-AS1 | NR_131238.1 | n.297+40432T>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOXF2B | ENST00000371402.5 | c.404A>C | p.Gln135Pro | missense_variant | 2/4 | 1 | NM_001099685.3 | ENSP00000360455.3 | ||
RHOXF1-AS1 | ENST00000553843.5 | n.297+40432T>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 2AN: 61553Hom.: 0 Cov.: 9 AF XY: 0.0000774 AC XY: 1AN XY: 12921 FAILED QC
GnomAD3 genomes
AF:
AC:
2
AN:
61553
Hom.:
Cov.:
9
AF XY:
AC XY:
1
AN XY:
12921
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000966 AC: 1AN: 103530Hom.: 0 AF XY: 0.0000356 AC XY: 1AN XY: 28128
GnomAD3 exomes
AF:
AC:
1
AN:
103530
Hom.:
AF XY:
AC XY:
1
AN XY:
28128
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000464 AC: 4AN: 862691Hom.: 0 Cov.: 27 AF XY: 0.0000164 AC XY: 4AN XY: 243531
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
4
AN:
862691
Hom.:
Cov.:
27
AF XY:
AC XY:
4
AN XY:
243531
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000325 AC: 2AN: 61553Hom.: 0 Cov.: 9 AF XY: 0.0000774 AC XY: 1AN XY: 12921
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
2
AN:
61553
Hom.:
Cov.:
9
AF XY:
AC XY:
1
AN XY:
12921
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.404A>C (p.Q135P) alteration is located in exon 2 (coding exon 2) of the RHOXF2B gene. This alteration results from a A to C substitution at nucleotide position 404, causing the glutamine (Q) at amino acid position 135 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of glycosylation at Q135 (P = 0.0522);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at